Libor Kostka

MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition

Lieselotte Vande Walle, Irma B. Stowe, Pavel Šácha et al. · PLoS Biology · 2019 · 149 citations · Full text

Immunology, Cell Death, Inflammation +16

Enhanced Tumor Uptake and Penetration of Virotherapy Using Polymer Stealthing and Focused Ultrasound

Robert Carlisle, James J. Choi, Miriam Bazán‐Peregrino et al. · JNCI Journal of the National Cancer Institute · 2013 · 117 citations · Full text

Coating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood components

Vladimír Šubr, Libor Kostka, Tom Selby-Milic et al. · Journal of Controlled Release · 2008 · 59 citations

Quaternary Amines Prevents, Engineering, Blood Components +6

Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance

Alena Braunová, Libor Kostka, Ladislav Sivák et al. · Journal of Controlled Release · 2016 · 51 citations

Nanomedicine, Block Co-polymers, Engineering +5

Dual fluorescent HPMA copolymers for passive tumor targeting with pH-sensitive drug release II: Impact of release rate on biodistribution

Petr Chytil, Stefan Hoffmann, Lucie Schindler et al. · Journal of Controlled Release · 2013 · 49 citations

Nanomedicine, Polymer-drug Conjugate, Passive Tumor +7